ZENAS BIOPHARMA, INC. (ZBIO)
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Office Properties Income Trust Completes Chapter 11 Reorganization
Global Ship Lease Announces Results of 2026 Annual Meeting of Shareholders
ICON Schedules First Quarter 2026 Earnings Conference Call
Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Clorox Announces Simplified Operating Structure to Improve Execution and Accelerate Growth
First Horizon Corporation to Announce Second Quarter Financial Results on July 15, 2026
ADT Joins Board of Directors of the Connectivity Standards Alliance, Reinforcing Its Role in Shaping the Future of the Connected Home
National Healthcare Properties Announces Preliminary Results of its Series A and Series B Preferred Stock Self Tender Offers
Rumble Closes Acquisition of Northern Data